Getinge (GETI) Q4 2008 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2008 earnings summary
27 Oct, 2026Executive summary
FY08 orders received rose 17.9% to SEK 19,447m, with 7.1% organic growth; net sales increased 17.2% to SEK 19,272m.
FY08 profit before tax increased 21.4% to SEK 2,155m; net profit rose 23.1% to SEK 1,552m and EPS increased 23.5% to SEK 7.37.
Q4 orders rose 23.6% to SEK 5,638m, with 5.1% organic growth; earnings remained strong and met expectations, with varied segment trends.
Financial highlights
Q4 net sales increased 24.6% to SEK 6,423m; gross profit rose 30.5% to SEK 3,074m and gross margin improved 2.2 percentage points to 47.9%.
Q4 operating profit increased 22.9% to SEK 1,270m; profit before tax rose 18.2% to SEK 1,066m and net profit increased 19.8% to SEK 767m.
FY08 gross margin was 48.6%, up 2.7 percentage points; operating profit rose 27.3% to SEK 2,906m, with a 15.1% operating margin.
EBITA excluding restructuring increased 31% to SEK 1,436m in Q4, with a 22.4% margin; FY08 adjusted EBITA rose 29.1% to SEK 3,456m, with a 17.9% margin.
Q4 included SEK 73m of restructuring expenses; operating cash flow rose 37.1% to SEK 747m.
Outlook and guidance
FY09 organic invoicing growth is expected to be somewhat lower than FY08, while demand and proprietary growth initiatives are expected to support continued good volume growth.
Continued strong earnings growth is anticipated from acquisition synergies, lower restructuring expenses, and strengthened products and production structure.
FY09 EBITA margin target is 18–19%, excluding restructuring; Extended Care expects a full-year margin of ~19%.
Datascope, including restructuring and financing expenses, is expected to have limited impact on FY09 profit before tax; earnings contribution is expected from 2010.
Latest events from Getinge
- A 15% annual growth ambition pairs acquisitions with organic growth and supply-chain gains.GETI
CMD 2006 presentation - Growth and margin ambitions center on international reach, supply-chain gains and Huntleigh integration.GETI
CMD 2007 presentation - Cash flow improved, but acquisition funding lifted net debt to MSEK 10,365.GETI
CMD 2008 presentation - Datascope deal adds cardiovascular scale, with earnings accretion expected by 2010.GETI
Acquisition presentation - EBITA rose 33.5% as margins strengthened; Huntleigh integration and the 2007 outlook remained on plan.GETI
Q1 2007 - Q2 adjusted EBITA rose 40.9% as sales grew 28%, with favourable 2007 guidance.GETI
Q2 2007 - Q3 adjusted EBITA rose 33% as strong orders offset Huntleigh integration costs.GETI
Q3 2007 - Sales grew 26.5%; Boston acquisition and margin targets set the next growth phase.GETI
Q4 2007 - Sales rose, but recession restrained organic growth as Datascope reshaped results.GETI
Q1 2009